<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39341822</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2059-0105</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>28</Day></PubDate></JournalIssue><Title>NPJ vaccines</Title><ISOAbbreviation>NPJ Vaccines</ISOAbbreviation></Journal><ArticleTitle>Development of T follicular helper cell-independent nanoparticle vaccines for SARS-CoV-2 or HIV-1 by targeting ICOSL.</ArticleTitle><Pagination><StartPage>176</StartPage><MedlinePgn>176</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">176</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41541-024-00971-4</ELocationID><Abstract><AbstractText>T helper cells, particularly T follicular helper (T<sub>FH</sub>) cells, are essential for the neutralizing antibody production elicited by pathogens or vaccines. However, in immunocompromised individuals, the inefficient support from T<sub>FH</sub> cells could lead to limited protection after vaccine inoculation. Here we showed that the conjugation of inducible T cell costimulatory (ICOS) onto the nanoparticle, together with immunogen, significantly enhanced the immune response of the vaccines specific for SARS-CoV-2 or human immunodeficiency virus type-1 (HIV-1) in T<sub>FH</sub>-deficient mice. Further studies indicated that ICOSL on B cells was triggered by ICOS binding, subsequently activated the PKCβ signaling pathway, and enhanced the survival and proliferation of B cells. Our findings revealed that the stimulation of ICOS-ICOSL interaction by adding ICOS on the nanoparticle vaccine significantly substitutes the function of T<sub>FH</sub> cells to support B cell response, which is significant for the immunocompromised people, such as the elderly or HIV-1-infected individuals.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Yongli</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Human Virology, Department of Pathogen Biology and Biosecurity, and Key Laboratory of Tropical Disease Control of Ministry of Education, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Chen</LastName><ForeName>Achun</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Human Virology, Department of Pathogen Biology and Biosecurity, and Key Laboratory of Tropical Disease Control of Ministry of Education, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Li</LastName><ForeName>Daiying</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of Human Virology, Department of Pathogen Biology and Biosecurity, and Key Laboratory of Tropical Disease Control of Ministry of Education, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Quyu</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Institute of Human Virology, Department of Pathogen Biology and Biosecurity, and Key Laboratory of Tropical Disease Control of Ministry of Education, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Airu</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Guangzhou Laboratory, Bio-island, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Jieyi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Human Virology, Department of Pathogen Biology and Biosecurity, and Key Laboratory of Tropical Disease Control of Ministry of Education, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yalin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Human Virology, Department of Pathogen Biology and Biosecurity, and Key Laboratory of Tropical Disease Control of Ministry of Education, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Human Virology, Department of Pathogen Biology and Biosecurity, and Key Laboratory of Tropical Disease Control of Ministry of Education, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Chaofeng</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Human Virology, Department of Pathogen Biology and Biosecurity, and Key Laboratory of Tropical Disease Control of Ministry of Education, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Wenjie</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Institute of Human Virology, Department of Pathogen Biology and Biosecurity, and Key Laboratory of Tropical Disease Control of Ministry of Education, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Qiannan</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Jiatong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Shenzhen College of International Education, No. 3 Antuoshan 6th Road, Futian District, Shenzhen, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiantao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Institute of Human Virology, Department of Pathogen Biology and Biosecurity, and Key Laboratory of Tropical Disease Control of Ministry of Education, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Institute of Human Virology, Department of Pathogen Biology and Biosecurity, and Key Laboratory of Tropical Disease Control of Ministry of Education, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yiwen</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Human Virology, Department of Pathogen Biology and Biosecurity, and Key Laboratory of Tropical Disease Control of Ministry of Education, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Ran</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Human Virology, Department of Pathogen Biology and Biosecurity, and Key Laboratory of Tropical Disease Control of Ministry of Education, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Ting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of Human Virology, Department of Pathogen Biology and Biosecurity, and Key Laboratory of Tropical Disease Control of Ministry of Education, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Infection and Immunity Study, School of Medicine, Sun Yat-sen University, Shenzhen, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Human Virology, Department of Pathogen Biology and Biosecurity, and Key Laboratory of Tropical Disease Control of Ministry of Education, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangzhou Laboratory, Bio-island, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Xin</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-2131-2092</Identifier><AffiliationInfo><Affiliation>Institute of Human Virology, Department of Pathogen Biology and Biosecurity, and Key Laboratory of Tropical Disease Control of Ministry of Education, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China. hexin59@mail.sysu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>32100743</GrantID><Agency>National Natural Science Foundation of China (National Science Foundation of China)</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>NPJ Vaccines</MedlineTA><NlmUniqueID>101699863</NlmUniqueID><ISSNLinking>2059-0105</ISSNLinking></MedlineJournalInfo><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>29</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>29</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>23</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39341822</ArticleId><ArticleId IdType="pmc">PMC11438966</ArticleId><ArticleId IdType="doi">10.1038/s41541-024-00971-4</ArticleId><ArticleId IdType="pii">10.1038/s41541-024-00971-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sette, A., Sidney, J. &amp; Crotty, S. T cell responses to SARS-CoV-2. Annu. Rev. Immunol.41, 343–373 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36750314</ArticleId></ArticleIdList></Reference><Reference><Citation>Cyster, J. G. &amp; Allen, C. D. C. B cell responses: cell interaction dynamics and decisions. Cell177, 524–540 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6538279</ArticleId><ArticleId IdType="pubmed">31002794</ArticleId></ArticleIdList></Reference><Reference><Citation>Victora, G. D. &amp; Nussenzweig, M. C. Germinal centers. Annu. Rev. Immunol.40, 413–442 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35113731</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwak, K., Akkaya, M. &amp; Pierce, S. K. B cell signaling in context. Nat. Immunol.20, 963–969 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31285625</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinuesa, C. G., Linterman, M. A., Yu, D. &amp; MacLennan, I. C. Follicular Helper T cells. Annu. Rev. Immunol.34, 335–368 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26907215</ArticleId></ArticleIdList></Reference><Reference><Citation>Crotty, S. T follicular helper cell differentiation, function, and roles in disease. Immunity41, 529–542 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4223692</ArticleId><ArticleId IdType="pubmed">25367570</ArticleId></ArticleIdList></Reference><Reference><Citation>Crotty, S. T follicular helper cell biology: a decade of discovery and diseases. Immunity50, 1132–1148 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6532429</ArticleId><ArticleId IdType="pubmed">31117010</ArticleId></ArticleIdList></Reference><Reference><Citation>Han, S. et al. Cellular interaction in germinal centers. Roles of CD40 ligand and B7-2 in established germinal centers. J. Immunol.155, 556–567 (1995).</Citation><ArticleIdList><ArticleId IdType="pubmed">7541819</ArticleId></ArticleIdList></Reference><Reference><Citation>McGuire, H. M. et al. IL-21 and IL-4 collaborate to shape T-dependent antibody responses. J. Immunol.195, 5123–5135 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26491200</ArticleId></ArticleIdList></Reference><Reference><Citation>Nurieva, R. I. et al. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity29, 138–149 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2556461</ArticleId><ArticleId IdType="pubmed">18599325</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenwald, R. J., Freeman, G. J. &amp; Sharpe, A. H. The B7 family revisited. Annu. Rev. Immunol.23, 515–548 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15771580</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, D. et al. T-B-cell entanglement and ICOSL-driven feed-forward regulation of germinal centre reaction. Nature517, 214–218 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25317561</ArticleId></ArticleIdList></Reference><Reference><Citation>Tafuri, A. et al. ICOS is essential for effective T-helper-cell responses. Nature409, 105–109 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11343123</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi, Y. S. et al. ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6. Immunity34, 932–946 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3124577</ArticleId><ArticleId IdType="pubmed">21636296</ArticleId></ArticleIdList></Reference><Reference><Citation>Roussel, L. et al. Loss of human ICOSL results in combined immunodeficiency. J. Exp. Med.215, 3151–3164 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6279397</ArticleId><ArticleId IdType="pubmed">30498080</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedl, M., Lahiri, A., Ning, K., Cho, J. H. &amp; Abraham, C. Pattern recognition receptor signaling in human dendritic cells is enhanced by ICOS ligand and modulated by the Crohn’s disease ICOSLG risk allele. Immunity40, 734–746 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4157904</ArticleId><ArticleId IdType="pubmed">24837102</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciabattini, A. et al. Vaccination in the elderly: The challenge of immune changes with aging. Semin. Immunol.40, 83–94 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30501873</ArticleId></ArticleIdList></Reference><Reference><Citation>Costiniuk, C. T. et al. COVID-19 vaccine immunogenicity in people with HIV. AIDS37, F1–F10 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9794000</ArticleId><ArticleId IdType="pubmed">36476452</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner, A. &amp; Weinberger, B. Vaccines to prevent infectious diseases in the older population: immunological challenges and future perspectives. Front. Immunol.11, 717 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7190794</ArticleId><ArticleId IdType="pubmed">32391017</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, A. et al. Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis. BMJ376, e068632 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8889026</ArticleId><ArticleId IdType="pubmed">35236664</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerqueira-Silva, T. et al. Influence of age on the effectiveness and duration of protection of Vaxzevria and CoronaVac vaccines: A population-based study. Lancet Reg. Health Am.6, 100154 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8692070</ArticleId><ArticleId IdType="pubmed">34957437</ArticleId></ArticleIdList></Reference><Reference><Citation>Collier, D. A. et al. Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2. Nature596, 417–422 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8373615</ArticleId><ArticleId IdType="pubmed">34192737</ArticleId></ArticleIdList></Reference><Reference><Citation>Doitsh, G. &amp; Greene, W. C. Dissecting how CD4 T cells are lost during HIV infection. Cell Host Microbe19, 280–291 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4835240</ArticleId><ArticleId IdType="pubmed">26962940</ArticleId></ArticleIdList></Reference><Reference><Citation>Cubas, R. A. et al. Inadequate T follicular cell help impairs B cell immunity during HIV infection. Nat. Med.19, 494–499 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3843317</ArticleId><ArticleId IdType="pubmed">23475201</ArticleId></ArticleIdList></Reference><Reference><Citation>Siliciano, J. D. et al. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat. Med.9, 727–728 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12754504</ArticleId></ArticleIdList></Reference><Reference><Citation>Perreau, M. et al. Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production. J. Exp. Med.210, 143–156 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3549706</ArticleId><ArticleId IdType="pubmed">23254284</ArticleId></ArticleIdList></Reference><Reference><Citation>Banga, R. et al. PD-1(+) and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals. Nat. Med.22, 754–761 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27239760</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu, F. et al. X4-Tropic Latent HIV-1 is enriched in peripheral follicular helper T cells and is correlated with disease progression. J. Virol.94, 10.1128/JVI.01219-19 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6955254</ArticleId><ArticleId IdType="pubmed">31666372</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindqvist, M. et al. Expansion of HIV-specific T follicular helper cells in chronic HIV infection. J. Clin. Invest.122, 3271–3280 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3428098</ArticleId><ArticleId IdType="pubmed">22922259</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrovas, C. et al. CD4 T follicular helper cell dynamics during SIV infection. J. Clin. Invest.122, 3281–3294 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3428091</ArticleId><ArticleId IdType="pubmed">22922258</ArticleId></ArticleIdList></Reference><Reference><Citation>Touizer, E. et al. Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV. Lancet HIV8, e317–e318 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8169058</ArticleId><ArticleId IdType="pubmed">34087093</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyarsky, B. J. et al. Antibody response to the Janssen COVID-19 vaccine in solid organ transplant recipients. Transplantation105, e82–e83 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8298284</ArticleId><ArticleId IdType="pubmed">34098566</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters, L. L., Raymer, D. S., Pal, J. D. &amp; Ambardekar, A. V. Association of COVID-19 vaccination with risk of COVID-19 infection, hospitalization, and death in heart transplant recipients. JAMA Cardiol.7, 651–654 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9047723</ArticleId><ArticleId IdType="pubmed">35475896</ArticleId></ArticleIdList></Reference><Reference><Citation>Piernas, C. et al. Associations of BMI with COVID-19 vaccine uptake, vaccine effectiveness, and risk of severe COVID-19 outcomes after vaccination in England: a population-based cohort study. Lancet Diabetes Endocrinol.10, 571–580 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9246477</ArticleId><ArticleId IdType="pubmed">35780805</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe, M. et al. Central obesity, smoking habit, and hypertension are associated with lower antibody titres in response to COVID-19 mRNA vaccine. Diabetes Metab. Res. Rev.38, e3465 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8209952</ArticleId><ArticleId IdType="pubmed">33955644</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal, R., Bhadada, S. K. &amp; Misra, A. COVID-19 vaccination in patients with diabetes mellitus: Current concepts, uncertainties and challenges. Diabetes Metab. Syndr.15, 505–508 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7904463</ArticleId><ArticleId IdType="pubmed">33662837</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma, X. et al. Nanoparticle vaccines based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit robust protective immune responses. Immunity53, 1315–1330 e1319 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7687490</ArticleId><ArticleId IdType="pubmed">33275896</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, X. et al. Improvement of a SARS-CoV-2 vaccine by enhancing the conjugation efficiency of the immunogen to self-assembled nanoparticles. Cell Mol. Immunol.18, 2042–2044 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8287548</ArticleId><ArticleId IdType="pubmed">34282299</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, X. et al. A mosaic nanoparticle vaccine elicits potent mucosal immune response with significant cross-protection activity against multiple SARS-CoV-2 sublineages. Adv. Sci. (Weinh.)10, e2301034 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10520630</ArticleId><ArticleId IdType="pubmed">37526323</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan, Y. et al. A bivalent nanoparticle vaccine exhibits potent cross-protection against the variants of SARS-CoV-2. Cell Rep.38, 110256 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8695190</ArticleId><ArticleId IdType="pubmed">34990583</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, R. et al. Development of Receptor Binding Domain (RBD)-conjugated nanoparticle vaccines with broad neutralization against SARS-CoV-2 Delta and other variants. Adv. Sci. (Weinh.)9, e2105378 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9008796</ArticleId><ArticleId IdType="pubmed">35142444</ArticleId></ArticleIdList></Reference><Reference><Citation>Saunders, K. O. et al. Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses. Nature, 10.1038/s41586-021-03594-0 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8528238</ArticleId><ArticleId IdType="pubmed">33971664</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulroney, T. E. et al. N(1)-methylpseudouridylation of mRNA causes +1 ribosomal frameshifting. Nature625, 189–194 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10764286</ArticleId><ArticleId IdType="pubmed">38057663</ArticleId></ArticleIdList></Reference><Reference><Citation>Heath, P. T. et al. Safety and efficacy of NVX-CoV2373 Covid-19 vaccine. N. Engl. J. Med.385, 1172–1183 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8262625</ArticleId><ArticleId IdType="pubmed">34192426</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollister, K. et al. Insights into the role of Bcl6 in follicular Th cells using a new conditional mutant mouse model. J. Immunol.191, 3705–3711 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3783642</ArticleId><ArticleId IdType="pubmed">23980208</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, H. et al. Follicular T-helper cell recruitment governed by bystander B cells and ICOS-driven motility. Nature496, 523–527 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23619696</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwai, H. et al. Involvement of inducible costimulator-B7 homologous protein costimulatory pathway in murine lupus nephritis. J. Immunol.171, 2848–2854 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12960306</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohyama, M. et al. Inducible costimulator-dependent IL-10 production by regulatory T cells specific for self-antigen. Proc. Natl Acad. Sci. USA101, 4192–4197 (2004).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC384717</ArticleId><ArticleId IdType="pubmed">15014176</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan, T. et al. Infection of wild-type mice by SARS-CoV-2 B.1.351 variant indicates a possible novel cross-species transmission route. Signal Transduct. Target Ther.6, 420 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8669038</ArticleId><ArticleId IdType="pubmed">34907154</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuai, H. et al. Emerging SARS-CoV-2 variants expand species tropism to murines. EBioMedicine73, 103643 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8530107</ArticleId><ArticleId IdType="pubmed">34689086</ArticleId></ArticleIdList></Reference><Reference><Citation>Steichen, J. M. et al. HIV vaccine design to target germline precursors of glycan-dependent broadly neutralizing antibodies. Immunity45, 483–496 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5040827</ArticleId><ArticleId IdType="pubmed">27617678</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki, A. &amp; Omer, S. B. Why and how vaccines work. Cell183, 290–295 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7560117</ArticleId><ArticleId IdType="pubmed">33064982</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamming, L. A. et al. DNA based vaccine expressing SARS-CoV-2 Spike-CD40L Fusion protein confers protection against challenge in a Syrian Hamster Model. Front Immunol.12, 785349 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8789660</ArticleId><ArticleId IdType="pubmed">35095861</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, L. et al. An adenoviral vector cancer vaccine that delivers a tumor-associated antigen/CD40-ligand fusion protein to dendritic cells. Proc. Natl Acad. Sci. USA100, 15101–15106 (2003).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC299915</ArticleId><ArticleId IdType="pubmed">14645711</ArticleId></ArticleIdList></Reference><Reference><Citation>Armitage, R. J., Macduff, B. M., Spriggs, M. K. &amp; Fanslow, W. C. Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. J. Immunol.150, 3671–3680 (1993).</Citation><ArticleIdList><ArticleId IdType="pubmed">8097223</ArticleId></ArticleIdList></Reference><Reference><Citation>Aragoneses-Fenoll, L. et al. Role of endocytosis and trans-endocytosis in ICOS costimulator-induced downmodulation of the ICOS Ligand. J. Leukoc. Biol.110, 867–884 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8597029</ArticleId><ArticleId IdType="pubmed">33527556</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, J. S. et al. High-affinity, neutralizing antibodies to SARS-CoV-2 can be made without T follicular helper cells. Sci. Immunol.7, eabl5652 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8977051</ArticleId><ArticleId IdType="pubmed">34914544</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu, H. et al. Noncanonical NF-kappaB regulates inducible costimulator (ICOS) ligand expression and T follicular helper cell development. Proc. Natl Acad. Sci. USA108, 12827–12832 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3150902</ArticleId><ArticleId IdType="pubmed">21768353</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, B. et al. Expression of ICOSL is associated with decreased survival in invasive breast cancer. PeerJ7, e6903 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6526018</ArticleId><ArticleId IdType="pubmed">31143539</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>